Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Human herpesvirus" patented technology

Affinity ligands for purification of herpesvirus vaccine antigens

PCT designated stageWO2026136802A2AntigenBiochemistry
Provided are human herpesvirus affinity ligands and related compositions including affinity resins.
Owner:REPLIGEN CORP

Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Oligomer nucleotides, compositions, methods, kits, and uses are provided for detecting or quantifying a Human Cytomegalovirus virus 1 (CMV (human herpesvirus 5, HHV5) nucleic acid, e.g., using nucleic acid amplification and hybridization assays. Multiphase amplification of a CMV target sequence is also described. The oligomer nucleotides, compositions, methods, kits, and uses can be used to amplify and / or detect the UL56 gene of CMV.
Owner:GEN PROBE INC

Application of MDVgC promoter in construction of recombinant herpes virus vector vaccine

The invention belongs to the technical field of gene engineering, and particularly relates to application of an MDVgC promoter in construction of a recombinant herpes virus vector vaccine. The heterologous gene expressed by the MDVgC promoter is inserted into the herpes virus, especially turkey herpes virus, Marek's disease virus, porcine pseudorabies virus, bovine herpes virus, duck plague virus, human herpes virus (type 1-8), canine herpes virus or feline herpes virus, and the constructed recombinant herpes virus vector vaccine can efficiently express the heterologous gene and is safe and effective.
Owner:SHANDONG UNIV